跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
FABRAZYME 5 mg powder for concentrate for solution for infusion - SFDA Drug Approval Details
Approvals
/
SFDA
/
FABRAZYME 5 mg powder for concentrate for solution for infusion
Authorized
BIOLOGICAL
FABRAZYME 5 mg powder for concentrate for solution for infusion
Unknown
🇸🇦 Saudi Food and Drug Authority
Approval Date
N/A
Approval ID
00775e1ed0acbf4b
Company
Unknown
Type
Biological
Approval Details
Approval Id
00775e1ed0acbf4b
Drug Approval Sfda Name
FABRAZYME 5 mg powder for concentrate for solution for infusion
Trade Name
FABRAZYME 5 mg powder for concentrate for solution for infusion
Generic Name
AGALSIDASE BETA
Register Number
5-832-16
Register Year
2016
Drug Type
Biological
Route Of Administration
Intravenous use
Package Type
Vial
Package Size
1
Size
1
Size Unit
ml
Legal Status
Prescription
Authorization Status
Valid
Marketing Status
Marketed
Product Control
Uncontrolled
Storage Conditions
store in a refrigerator (2°c – 8°c)
Shelf Life
36 Months
Distribution Site
Hospital
Description Code
7000000027-5-100000074029
Price
2129.95
Active Ingredients
Authorized
Quick Info
Agency
SFDA
Country
🇸🇦
Approval ID
00775e1ed0acbf4b
Type
Biological
Back to SFDA Approvals